Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-037242
Filing Date
2024-03-27
Accepted
2024-03-27 16:31:09
Documents
124
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K gyre-20231231.htm   iXBRL 10-K 4377013
2 EX-3.6(B) gyre-ex3_6b.htm EX-3.6(B) 12439
3 EX-4.1 gyre-ex4_1.htm EX-4.1 44294
4 EX-21.1 gyre-ex21_1.htm EX-21.1 9244
5 EX-23.1 gyre-ex23_1.htm EX-23.1 4082
6 EX-31.1 gyre-ex31_1.htm EX-31.1 14769
7 EX-31.2 gyre-ex31_2.htm EX-31.2 14558
8 EX-32.1 gyre-ex32_1.htm EX-32.1 7904
9 EX-32.2 gyre-ex32_2.htm EX-32.2 7734
10 EX-97.1 gyre-ex97_1.htm EX-97.1 32423
11 GRAPHIC img98921446_0.jpg GRAPHIC 108531
12 GRAPHIC img98921446_1.jpg GRAPHIC 165653
13 GRAPHIC img98921446_2.jpg GRAPHIC 2311
14 GRAPHIC img98921446_3.jpg GRAPHIC 155614
15 GRAPHIC img98921446_4.jpg GRAPHIC 24230
16 GRAPHIC img98921446_5.jpg GRAPHIC 113011
  Complete submission text file 0000950170-24-037242.txt   18521271

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT gyre-20231231.xsd EX-101.SCH 2449568
128 EXTRACTED XBRL INSTANCE DOCUMENT gyre-20231231_htm.xml XML 2911487
Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51173 | Film No.: 24791282
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)